Pre-made Latozinemab benchmark antibody ( Whole mAb, anti-SORT1 therapeutic antibody, Anti-Gp95/LDLCQ6/NT3/NTR3 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-ab-298

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-ab-298 Category Tag

Product Details

Pre-Made Latozinemab biosimilar, Whole mAb, Anti-SORT1 Antibody: Anti-Gp95/LDLCQ6/NT3/NTR3 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Action and use: Molecular formula, Chemical Abstracts Service (CAS) registry number: Graphic formula.

Products Name (INN Index)

Pre-Made Latozinemab biosimilar, Whole mAb, Anti-SORT1 Antibody: Anti-Gp95/LDLCQ6/NT3/NTR3 therapeutic antibody

INN Name

Latozinemab

Target

SORT1

Format

Whole mAb

Derivation

NA

Species Reactivity

Human

CH1 Isotype

IgG1

VD LC

Kappa

Highest_Clin_Trial (Jan '20)

Phase-III

Est. Status

Active

100% SI Structure

None

99% SI Structure

None

95-98% SI Structure

None

Year Proposed

2020

Companies

Alector

Conditions Approved

NA

Conditions Active

Frontotemporal dementia

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

SORT1

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide